AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ABACAVIR SULFATE; LAMIVUDINE in Zimbabwe
3 products registered with MCAZ — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ABACAVIR SULPHATE; LAMIVUDINE TABLET, COATED; ORAL | 2019/7.13/5941 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 5 May 2029 |
| ABACAVIR SULFATE; LAMIVUDINE TABLET, COATED; ORAL | 2018/7.13/5521 | AUROBINDO PHARMA LIMITED | active | 31 Dec 2027 |
| ABACAVIR SULFATE; LAMIVUDINE TABLET; ORAL | 2018/7.13/5589 | MYLAN LABORATORIES LIMITED | active | 31 Dec 2027 |
ABACAVIR SULFATE; LAMIVUDINE — MCAZ Registration Details
MCAZ (Zimbabwe) has 3 registered products containing ABACAVIR SULFATE; LAMIVUDINE, of which 3 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ABACAVIR SULFATE; LAMIVUDINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.